Importance of the aromatic residue at position 6 of [Nle10]neurokinin A(4-10) for binding to the NK-2 receptor and receptor activation

被引:13
作者
Gembitsky, DS
Murnin, M
Ötvös, FL
Allen, J
Murphy, RF
Lovas, S
机构
[1] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA
[2] Univ Ulster, Biomed Sci Res Ctr, Coleraine BT52 1SA, Londonderry, North Ireland
关键词
D O I
10.1021/jm9807151
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Steric and electrostatic requirements at position 6 of [Nle(10)]NKA(4-10), a full agonist of NK-2 receptors, for molecular recognition by the receptor were studied. Two series of peptide analogues, (a) p-substituted analogues, [p-X-Phe(6),Nle(10)]NKA(4-10), where X = F, Cl, Br, I, NH2, NO2, and (b) [D-Phe(6),Nle(10)]NKA(4-10), [Trp(6),Nle(10)]NKA(4-10), and [Chex-Ala(6),Nle(10)]NKA(4-10), were synthesized, and their biological activity was examined. Competition binding experiments with [H-3]NKA were performed using cloned human NK-2 receptors expressed in CHO cells. Antagonistic and agonistic properties of the analogues were studied using an in vitro functional assay with hamster tracheal rings. The rank order of potency of agonists was [Nle(10)]NKA(4-10) approximate to [p-F-Phe(6),Nle(10)]NKA(4-10) > [p-NH2-Phe(6),Nle(10)]NKA(4-10) > [p-Cl-Phe(6),Nle(10)]NKA(4-10) > [p-NO2-Phe(6),Nle(10)]NKA(4-10) > [Trp(6),Nle(10)]NKA(4-10). Size and planarity of the aromatic side chain were crucially important for the biological activity, whereas electran-donating and electron-withdrawing properties of the para-substituent were less important;. The results favor the hypothesis that weakly polar pi-pi interactions exist between the aromatic group and the receptor.
引用
收藏
页码:3004 / 3007
页数:4
相关论文
共 23 条
[11]  
LOVAS S, 1993, PEPTIDES 1992, P515
[12]   THE MAMMALIAN TACHYKININ RECEPTORS [J].
MAGGI, CA .
GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 1995, 26 (05) :911-944
[13]   TACHYKININ RECEPTORS IN SMOOTH MUSCLES - A STUDY WITH AGONISTS (SUBSTANCE-P, NEUROKININ-A) AND ANTAGONISTS [J].
MIZRAHI, J ;
DION, S ;
DORLEANSJUSTE, P ;
ESCHER, E ;
DRAPEAU, G ;
REGOLI, D .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 118 (1-2) :25-36
[14]  
Moore G J, 1995, Adv Pharmacol, V33, P91, DOI 10.1016/S1054-3589(08)60667-5
[15]  
NAKANISHI S, 1991, ANNU REV NEUROSCI, V14, P123, DOI 10.1146/annurev.neuro.14.1.123
[16]   THE CONTRACTILE ACTIVITIES OF NEUROKININ A, B AND RELATED PEPTIDES ON SMOOTH MUSCLES [J].
OSAKADA, F ;
KUBO, K ;
GOTO, K ;
KANAZAWA, I ;
MUNEKATA, E .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 120 (02) :201-208
[17]   FURTHER EVIDENCE FOR THE EXISTENCE OF NK2 TACHYKININ RECEPTOR SUBTYPES [J].
PATACCHINI, R ;
ASTOLFI, M ;
QUARTARA, L ;
ROVERO, P ;
GIACHETTI, A ;
MAGGI, CA .
BRITISH JOURNAL OF PHARMACOLOGY, 1991, 104 (01) :91-96
[18]  
PATERSON SJ, 1984, NEUROPEPTIDES, V5, P177, DOI 10.1016/0143-4179(84)90056-8
[19]   ABSOLUTE ELECTRONEGATIVITY AND HARDNESS - APPLICATIONS TO ORGANIC-CHEMISTRY [J].
PEARSON, RG .
JOURNAL OF ORGANIC CHEMISTRY, 1989, 54 (06) :1423-1430
[20]   NEUROKININ RECEPTOR SUBTYPES CHARACTERIZED BY BIOLOGICAL ASSAYS [J].
REGOLI, D ;
NGUYEN, QT ;
JUKIC, D .
LIFE SCIENCES, 1994, 54 (26) :2035-2047